Clinical Trials Browser

Precursor Cell Lymphoblastic Leukemia-Lymphoma × Biological Products × Clear all

NCT01430390 2025-06-11

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06777264 2025-01-15

JUVENTAS-ALL05

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma